Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis (ENTERPRET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03029143
Recruitment Status : Recruiting
First Posted : January 24, 2017
Last Update Posted : September 4, 2019
Sponsor:
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 26, 2020
Estimated Study Completion Date : June 30, 2020